News MatsukiyoCocokara & Co.

Stocks

3088

JP3869010003

Drug Retailers

Market Closed - Japan Exchange Other stock markets 07:30:00 11/06/2026 BST			5-day change	1st Jan Change
2,358.00 ^JPY	-1.26%		+4.89%	-13.05%

05-14	MatsukiyoCocokara & Co.'s Equity Buyback announced on May 13, 2026, has closed with 4,617,700 shares, representing 1.16% for ¥10,745.39 million.	CI
05-14	Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 13, 2026.	CI

All News

Mentions Relevance

05-14	MatsukiyoCocokara & Co.'s Equity Buyback announced on May 13, 2026, has closed with 4,617,700 shares, representing 1.16% for ¥10,745.39 million.	CI
05-14	Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 13, 2026.	CI
05-14	Matsukiyococokara & Co - to retire treasury shares worth 1.16% of outstanding stock on May 29	RE
05-13	MatsukiyoCocokara & Co. announces an Equity Buyback for 5,000,000 shares, representing 1.26% for ¥11,635 million.	CI
05-13	Matsukiyococokara & Co. Provides Consolidated Earnings Guidance for the Fiscal First Half Ending September 30, 2026 and Full Year Ending March 31, 2027	CI
05-13	Matsukiyococokara & Co. Revises Dividend for the Fiscal Full Year Ended March 31, 2026, Payable on June 22, 2026; Provides Dividend Guidance for the Second Quarter and Fiscal Year-Ending March 31, 2027	CI
05-13	MatsukiyoCocokara & Co. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-12	MatsukiyoCocokara & Co. authorizes a Buyback Plan.	CI
03-29	Final dividend	FA
02-13	MatsukiyoCocokara & Co. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026	CI
02-13	MatsukiyoCocokara & Co. Announces Executive and Board Changes, Effective April 1, 2026	CI
02-12	MatsukiyoCocokara & Co. Reports Earnings Results for the Nine Months Ended December 31, 2025	CI
11-13	MatsukiyoCocokara & Co. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 2, 2025 and Provides Year End Dividend Guidance for the Year Ending March 31, 2026	CI
11-13	MatsukiyoCocokara & Co. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026	CI
11-13	MatsukiyoCocokara & Co's Attributable Profit Rises 6.2% in Fiscal H1	MT
11-13	MatsukiyoCocokara & Co. Reports Earnings Results for the Half Year Ended September 30, 2025	CI
28/09/25	For interim dividend	FA
26/09/25	MatsukiyoCocokara expands Kyushu footprint
22/09/25	Matsukiyococokara & Co - group company Cocokara Fine Healthcare to acquire 7 stores in Osaka and Nara from Sigma Medical Co	RE
13/08/25	MatsukiyoCocokara & Co's Profit Climbs 11% in Fiscal Q1	MT
13/08/25	Matsukiyococokara & Co: to acquire 100% stake in Shinseidoyakkyoku Co, which operates 119 pharmacies and drugstores in Japan, for undisclosed price	RE
13/08/25	MatsukiyoCocokara & Co. Provides Consolidated Earnings Guidance for the six months ending September 30, 2025 and Full Year Ending March 31, 2026	CI
12/05/25	MatsukiyoCocokara & Co Profit Gains 4.4% in Fiscal 2024	MT
12/05/25	Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 9, 2025.	CI
11/05/25	MatsukiyoCocokara & Co.'s Equity Buyback announced on May 9, 2025, has closed with 5,399,800 shares, representing 1.34% for ¥14,471.46 million.	CI